GROENHUYSEN WILHELMUS CM
SEC CIK 1264783 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | COO | 252.3K | — | $2.84M | 21 | 2021-07-06 | 2024-06-28 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
GROENHUYSEN WILHELMUS CM made no open-market trades at NVCR in the last 12 months.
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-06 | 2024-06-28 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $12.24 | +1,055 | 252.3K | +0.4% | +$12.9K | |
| DI | 2024-06-07 | 2024-06-05 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | M - OptEx | $22.82 | +124.4K | 124.4K | New | +$2.84M |
| M | 2024-03-05 | 2024-03-01+ | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $16.02 | -3,324 | 251.2K | -1% | -$53.3K |
| D | 2024-02-29 | 2024-02-28 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $16.14 | -2,303 | 254.6K | -0.9% | -$37.2K |
| DM | 2024-02-29 | 2023-12-31+ | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $16.30 | +47.0K | 209.8K | +29% | +$766.7K |
| 2023-09-05 | 2023-09-01 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $21.82 | -294 | 209.8K | -0.1% | -$6,415 | |
| 2023-07-06 | 2023-06-30 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $35.28 | +366 | 210.1K | +0.2% | +$12.9K | |
| M | 2023-03-07 | 2023-03-03 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $76.16 | -25.6K | 231.9K | -10% | -$1.95M |
| M | 2023-03-06 | 2023-03-03 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $0.00 | +52.0K | 231.5K | +29% | $0 |
| 2023-03-06 | 2023-03-02 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $75.28 | -1,213 | 183.4K | -0.7% | -$91.3K | |
| D | 2023-03-02 | 2023-03-01 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $76.36 | -2,164 | 184.6K | -1% | -$165.2K |
| D | 2023-03-02 | 2023-02-28 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $0.00 | +21.7K | 186.8K | +13% | $0 |
| 2023-01-10 | 2023-01-06 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $62.31 | +102 | 165.1K | +0.1% | +$6,356 | |
| 2022-09-06 | 2022-09-02 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $79.04 | -296 | 165.0K | -0.2% | -$23.4K | |
| 2022-07-07 | 2022-07-05 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $59.08 | +218 | 165.3K | +0.1% | +$12.9K | |
| 2022-03-09 | 2022-03-08 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $70.10 | -2,923 | 165.1K | -2% | -$204.9K | |
| DM | 2022-03-07 | 2022-03-03+ | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $71.78 | -3,870 | 170.6K | -2% | -$277.8K |
| D | 2022-03-07 | 2022-03-03 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $0.00 | +21.9K | 171.9K | +15% | $0 |
| 2022-01-12 | 2022-01-06 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $63.82 | +75 | 150.0K | +0.1% | +$4,786 | |
| 2021-09-07 | 2021-09-02 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | S - Sale | $138.23 | -181 | 149.9K | -0.1% | -$25.0K | |
| 2021-07-08 | 2021-07-06 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | COO | A - Grant | $137.12 | +66 | 150.1K | +0.0% | +$9,050 |
Purchase Sale Sale after option exercise All abbreviations